M Wallesch1, M Wirth1, B Wollenberg2. 1. Klinik und Poliklinik für Hals‑, Nasen- und Ohren Heilkunde des Klinikums rechts der Isar, Technische Universität München, Ismaninger Straße 22, 81675, München, Deutschland. 2. Klinik und Poliklinik für Hals‑, Nasen- und Ohren Heilkunde des Klinikums rechts der Isar, Technische Universität München, Ismaninger Straße 22, 81675, München, Deutschland. barbara.wollenberg@tum.de.
Abstract
BACKGROUND: Clinical application of immune checkpoint inhibitors (ICI), whether as monotherapy or in combination with established methods, is revolutionizing treatment of head and neck cancer. However, this change in therapeutic concepts requires reevaluation and further development of predictive and prognostic markers, since the survival rates for advanced and particularly human papillomavirus (HPV)-negative disease remain poor. MATERIALS AND METHODS: A selective literature review was performed in PubMed. Literature found with the keywords "cytodiagnostics, circulating tumor cells, liquid biopsy, cfDNA, exosomes" in combination with "head and neck cancer" and/or "immune checkpoint inhibitor therapy" published until March 2020 was included. The articles were selected for their relevance for the current study by the authors. RESULTS: This work provides a review of the current literature and indicates possible applications in the field of head and neck cancers. Liquid biopsy refers to the analysis of circulating tumor cells or of tumor genetic material in body fluids. This minimally invasive analysis can support therapeutic decisions and enable a personalized approach to treating head and neck cancer. DISCUSSION: Before any of these approaches can be established in clinical routine, long-term data and standardization of the methods for isolating and analyzing the markers are needed.
BACKGROUND: Clinical application of immune checkpoint inhibitors (ICI), whether as monotherapy or in combination with established methods, is revolutionizing treatment of head and neck cancer. However, this change in therapeutic concepts requires reevaluation and further development of predictive and prognostic markers, since the survival rates for advanced and particularly human papillomavirus (HPV)-negative disease remain poor. MATERIALS AND METHODS: A selective literature review was performed in PubMed. Literature found with the keywords "cytodiagnostics, circulating tumor cells, liquid biopsy, cfDNA, exosomes" in combination with "head and neck cancer" and/or "immune checkpoint inhibitor therapy" published until March 2020 was included. The articles were selected for their relevance for the current study by the authors. RESULTS: This work provides a review of the current literature and indicates possible applications in the field of head and neck cancers. Liquid biopsy refers to the analysis of circulating tumor cells or of tumor genetic material in body fluids. This minimally invasive analysis can support therapeutic decisions and enable a personalized approach to treating head and neck cancer. DISCUSSION: Before any of these approaches can be established in clinical routine, long-term data and standardization of the methods for isolating and analyzing the markers are needed.
Entities:
Keywords:
Circulating tumor cells; Cytodiagnosis; Exosomes; Head and neck neoplasms; Immunotherapy
Authors: Alice Bernard-Tessier; Emmanuelle Jeannot; David Guenat; Alice Debernardi; Marc Michel; Charlotte Proudhon; Anne Vincent-Salomon; Ivan Bièche; Jean-Yves Pierga; Bruno Buecher; Aurélia Meurisse; Éric François; Romain Cohen; Marine Jary; Véronique Vendrely; Emmanuelle Samalin; Farid El Hajbi; Nabil Baba-Hamed; Christophe Borg; François-Clément Bidard; Stefano Kim Journal: Clin Cancer Res Date: 2018-11-30 Impact factor: 12.531
Authors: K C Allen Chan; Emily C W Hung; John K S Woo; Paul K S Chan; Sing-Fai Leung; Franco P T Lai; Anita S M Cheng; Sze Wan Yeung; Yin Wah Chan; Teresa K C Tsui; Jeffrey S S Kwok; Ann D King; Anthony T C Chan; Andrew C van Hasselt; Y M Dennis Lo Journal: Cancer Date: 2013-02-21 Impact factor: 6.860
Authors: Luc Cabel; Emmanuelle Jeannot; Ivan Bieche; Sophie Vacher; Celine Callens; Louis Bazire; Adeline Morel; Alice Bernard-Tessier; Walid Chemlali; Anne Schnitzler; Astrid Lièvre; Joelle Otz; Mathieu Minsat; Anne Vincent-Salomon; Jean-Yves Pierga; Bruno Buecher; Pascale Mariani; Charlotte Proudhon; François-Clément Bidard; Wulfran Cacheux Journal: Clin Cancer Res Date: 2018-07-27 Impact factor: 12.531
Authors: Frank Diehl; Kerstin Schmidt; Michael A Choti; Katharine Romans; Steven Goodman; Meng Li; Katherine Thornton; Nishant Agrawal; Lori Sokoll; Steve A Szabo; Kenneth W Kinzler; Bert Vogelstein; Luis A Diaz Journal: Nat Med Date: 2007-07-31 Impact factor: 53.440
Authors: Fernando Concha-Benavente; Raghvendra M Srivastava; Sumita Trivedi; Yu Lei; Uma Chandran; Raja R Seethala; Gordon J Freeman; Robert L Ferris Journal: Cancer Res Date: 2015-12-16 Impact factor: 12.701
Authors: Daniel L Adams; Diane K Adams; Jianzhong He; Neda Kalhor; Ming Zhang; Ting Xu; Hui Gao; James M Reuben; Yawei Qiao; Ritsuko Komaki; Zhongxing Liao; Martin J Edelman; Cha-Mei Tang; Steven H Lin Journal: Clin Cancer Res Date: 2017-07-05 Impact factor: 12.531